D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 21,211 254 World Ranking 13618 National Ranking 7045

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

His primary areas of investigation include Internal medicine, Acquired immunodeficiency syndrome, Cohort study, Tuberculosis and Cohort. The various areas that Timothy R. Sterling examines in his Internal medicine study include Antibacterial agent, Surgery, Immunology and Oncology. His Acquired immunodeficiency syndrome research includes themes of Young adult, Gerontology, Viral load, Life expectancy and Hazard ratio.

The Cohort study study combines topics in areas such as Antiretroviral therapy, Incidence, Sida and Comorbidity. Tuberculosis is closely attributed to Intensive care in his study. Timothy R. Sterling interconnects Body mass index and Hepatitis C in the investigation of issues within Cohort.

His most cited work include:

  • Effect of early versus deferred antiretroviral therapy for HIV on survival. (970 citations)
  • The emergence of drug-resistant tuberculosis in New York City. (812 citations)
  • Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. (806 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Tuberculosis, Immunology, Cohort and Acquired immunodeficiency syndrome. Timothy R. Sterling focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Surgery and, in certain cases, Pediatrics. His Tuberculosis study integrates concerns from other disciplines, such as Disease and Intensive care medicine.

His biological study spans a wide range of topics, including Body mass index, Young adult, Hazard ratio, Coinfection and Survival analysis. His studies deal with areas such as Viral disease, Epidemiology, Viral load and Gerontology as well as Acquired immunodeficiency syndrome. His studies in Cohort study integrate themes in fields like Mortality rate, Incidence and Antiretroviral therapy.

He most often published in these fields:

  • Internal medicine (52.52%)
  • Tuberculosis (46.23%)
  • Immunology (31.13%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (52.52%)
  • Tuberculosis (46.23%)
  • Cohort (29.25%)

In recent papers he was focusing on the following fields of study:

Timothy R. Sterling focuses on Internal medicine, Tuberculosis, Cohort, Latent tuberculosis and Acquired immunodeficiency syndrome. His study looks at the relationship between Internal medicine and topics such as Raltegravir, which overlap with Integrase inhibitor. His work deals with themes such as Logistic regression, Epidemiology and Immunology, which intersect with Tuberculosis.

His Cohort research incorporates elements of Body mass index, Hepatitis B, Retrospective cohort study, Hazard ratio and Hepatitis B virus. His research in Latent tuberculosis intersects with topics in Odds ratio, Clinical trial, Regimen, Tuberculin and Disease. His Acquired immunodeficiency syndrome research integrates issues from Cancer registry and Cumulative incidence.

Between 2018 and 2021, his most popular works were:

  • Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy. (82 citations)
  • Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 (40 citations)
  • Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women (28 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Timothy R. Sterling mostly deals with Tuberculosis, Internal medicine, Acquired immunodeficiency syndrome, Latent tuberculosis and Cohort. His Tuberculosis study combines topics in areas such as Disease and Immunology. His research integrates issues of Calcitriol receptor and Macrophage in his study of Immunology.

In his articles, Timothy R. Sterling combines various disciplines, including Internal medicine and Weight gain. His Acquired immunodeficiency syndrome research is multidisciplinary, relying on both Meningitis, Logistic regression, Interquartile range, Epidemiology and Lost to follow-up. Timothy R. Sterling has researched Cohort in several fields, including Immunosuppression, Anal cancer, Viral load, Long-term care and Lymphoma.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Mari M. Kitahata;Stephen J. Gange;Alison G. Abraham;Barry Merriman.
The New England Journal of Medicine (2009)

1530 Citations

The emergence of drug-resistant tuberculosis in New York City.

Thomas R. Frieden;Timothy Sterling;Ariel Pablos-Mendez;James O. Kilburn.
The New England Journal of Medicine (1993)

1345 Citations

An official ATS statement: hepatotoxicity of antituberculosis therapy.

Jussi J. Saukkonen;David L. Cohn;Robert M. Jasmer;Steven Schenker.
American Journal of Respiratory and Critical Care Medicine (2006)

1187 Citations

Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

Hasina Samji;Angela Cescon;Robert S. Hogg;Robert S. Hogg;Sharada P. Modur.
PLOS ONE (2013)

1171 Citations

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

Timothy R. Sterling;M. Elsa Villarino;Andrey S. Borisov;Nong Shang.
The New England Journal of Medicine (2011)

852 Citations

Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

Adam Trickey;Margaret T May;Jorg-Janne Vehreschild;Niels Obel.
The Lancet HIV (2017)

596 Citations

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Haileyesus Getahun;Alberto Matteelli;Ibrahim Abubakar;Mohamed Abdel Aziz.
European Respiratory Journal (2015)

518 Citations

Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America

Michael J. Silverberg;Bryan Lau;Amy C. Justice;Amy C. Justice;Eric Engels.
Clinical Infectious Diseases (2012)

486 Citations

Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis

Amitabh B. Suthar;Stephen D. Lawn;Stephen D. Lawn;Julia del Amo;Haileyesus Getahun.
PLOS Medicine (2012)

401 Citations

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children

David M. Lewinsohn;Michael K. Leonard;Philip A. LoBue;David L. Cohn.
Clinical Infectious Diseases (2017)

359 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Timothy R. Sterling

Amy C. Justice

Amy C. Justice

Yale University

Publications: 130

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 106

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 96

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 86

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 68

Joseph J. Eron

Joseph J. Eron

University of North Carolina at Chapel Hill

Publications: 59

Matthias Egger

Matthias Egger

University of Bern

Publications: 58

Caroline Sabin

Caroline Sabin

University College London

Publications: 56

Michael J. Mugavero

Michael J. Mugavero

University of Alabama at Birmingham

Publications: 52

Dick Menzies

Dick Menzies

McGill University

Publications: 51

Giovanni Battista Migliori

Giovanni Battista Migliori

Queen Mary University of London

Publications: 51

Anthony D. Harries

Anthony D. Harries

International Union Against Tuberculosis and Lung Disease

Publications: 46

Richard E. Chaisson

Richard E. Chaisson

Johns Hopkins University

Publications: 45

Michael J. Silverberg

Michael J. Silverberg

Kaiser Permanente

Publications: 45

Dominique Costagliola

Dominique Costagliola

Université Paris Cité

Publications: 45

David Rimland

David Rimland

Emory University

Publications: 44

Trending Scientists

Anastasios N. Venetsanopoulos

Anastasios N. Venetsanopoulos

Toronto Metropolitan University

Victor S. Batista

Victor S. Batista

Yale University

Claude Leforestier

Claude Leforestier

University of Montpellier

Paulo Roberto Bueno

Paulo Roberto Bueno

Sao Paulo State University

Hesheng Xia

Hesheng Xia

Sichuan University

Yongye Liang

Yongye Liang

Southern University of Science and Technology

Zejun Zhang

Zejun Zhang

China West Normal University

Bruce D. Gossen

Bruce D. Gossen

Agriculture and Agriculture-Food Canada

Yasuo Ohnishi

Yasuo Ohnishi

University of Tokyo

John Parkinson

John Parkinson

University of Toronto

James B. Gill

James B. Gill

University of California, Santa Cruz

William S. D. Wilcock

William S. D. Wilcock

University of Washington

Damien D. Pearse

Damien D. Pearse

University of Miami

Shane J. Lopez

Shane J. Lopez

University of Kansas

Patricia J. Deldin

Patricia J. Deldin

University of Michigan–Ann Arbor

Ezra E.W. Cohen

Ezra E.W. Cohen

University of California, San Diego

Something went wrong. Please try again later.